| Health / Medical Topics |
EZN-2285
A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the anticancer drug PEG-asparaginase that stays in the body longer. EZN-2285 is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor. Also called Oncaspar-IV and SC-PEG E. coli L-asparaginase. (NCI Dictionary)
YOU MAY ALSO LIKE
Human EZH2 wild-type allele is located within 7q35-q36 and is approximately 77 kb in length. This allele, which encodes enhancer of zeste…
A molecular genetic abnormality that refers to the presence of a mutation in the histone methyltransferase gene EZH2.
This gene plays a role in chromatin remodeling and transcriptional regulation.
An azetidinone derivative and a cholesterol absorption inhibitor with lipid-lowering activity. Ezetimibe appears to interact physically with cholesterol transporters at the brush…
A liposomal small-molecule glutathione analog inhibitor of glutathione S-transferase (GST) P1-1 with hematopoiesis-stimulating activity. After intracellular de-esterification, the active form of TLK199…
Eyes absent homolog 1 (592 aa, ~65 kDa) is encoded by the human EYA1 gene. This protein may play a role in…
